GSA Capital Partners’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,911
Closed -$241K 1813
2019
Q3
$241K Sell
4,911
-878
-15% -$38.6K 0.03% 1072
2019
Q2
$262K Buy
5,789
+1,935
+50% +$91.5K 0.03% 1087
2019
Q1
$167K Buy
+3,854
New +$186K 0.02% 1275
2018
Q3
Sell
-996
Closed -$179K 1985
2018
Q2
$179K Buy
+996
New +$232K 0.01% 1552
2017
Q4
Sell
-1,889
Closed -$572K 1888
2017
Q3
$572K Buy
1,889
+560
+42% +$146K 0.04% 886
2017
Q2
$311K Buy
1,329
+1,189
+849% +$311K 0.02% 1260
2017
Q1
$47K Buy
+140
New +$33.8K ﹤0.01% 1696
2016
Q4
Sell
-519
Closed -$180K 2017
2016
Q3
$180K Buy
+519
New +$137K 0.01% 1630

Other funds holding ACGN

GSA Capital Partners's ACGN Position: Q4 2019 in Review

GSA Capital Partners sold out of Aceragen Inc (ACGN) in Q4 2019, closing a stake of 4,911 shares — an estimated $241K sold.

GSA Capital Partners first reported a position in ACGN in Q3 2016 and held it in 8 quarters. The position peaked at $572K in Q3 2017. 50 funds tracked by Wall St. Rank hold ACGN as of Q4 2019.

  • GSA Capital Partners reported no remaining Aceragen Inc position as of Q4 2019 after selling out during the quarter.
  • GSA Capital Partners sold 4,911 Aceragen Inc shares in Q4 2019, an estimated $241K.
  • GSA Capital Partners first reported a position in Aceragen Inc in Q3 2016 and held it in 8 quarters.
  • GSA Capital Partners's Aceragen Inc position peaked at $572K in Q3 2017.
  • 50 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2019.

Based on GSA Capital Partners's 13F filing for Q4 2019, filed 12 Feb 2020.